Squarepoint
XBIT icon

Squarepoint’s XBiotech XBIT Stock Holding History

Squarepoint’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.9K Sell
41,214
-22,790
-36% -$55.1K ﹤0.01% 4074
2025
Q4 		$153K Buy
64,004
+1,845
+3% +$4.55K ﹤0.01% 3945
2025
Q3 		$165K Buy
62,159
+22,383
+56% +$66.3K ﹤0.01% 3997
2025
Q2 		$118K Buy
+39,776
New +$116K ﹤0.01% 4127
2024
Q1 		– Sell
-18,922
Closed -$75.7K – 4686
2023
Q4 		$75.7K Buy
+18,922
New +$75.4K ﹤0.01% 3796
2022
Q3 		– Sell
-11,189
Closed -$63K – 3513
2022
Q2 		$63K Buy
+11,189
New +$75.3K ﹤0.01% 2687
2020
Q2 		– Sell
-11,415
Closed -$121K – 2554
2020
Q1 		$121K Sell
11,415
-25,608
-69% -$417K ﹤0.01% 1602
2019
Q4 		$691K Buy
37,023
+24,135
+187% +$311K ﹤0.01% 1568
2019
Q3 		$135K Buy
+12,888
New +$105K ﹤0.01% 2151

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's XBIT Position: Q1 2026 in Review

Squarepoint reduced its XBiotech (XBIT) stake by 36% in Q1 2026, selling an estimated $55.1K and leaving 41,214 shares worth $96.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4074.

Squarepoint first reported a position in XBIT in Q3 2019 and has held it in 9 quarters since. The position peaked at $691K in Q4 2019. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Squarepoint held 41,214 shares of XBiotech worth $96.9K as of Q1 2026.
  • Squarepoint sold 22,790 XBiotech shares in Q1 2026, an estimated $55.1K.
  • XBiotech made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4074 holding.
  • Squarepoint first reported a position in XBiotech in Q3 2019 and has held it in 9 quarters since.
  • Squarepoint's XBiotech position peaked at $691K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.